CSIMarket
 
Biosig Technologies Inc   (BSGM)
Other Ticker:  
 
 
Price: $0.5302 $0.00 0.227%
Day's High: $0.65 Week Perf: 0.04 %
Day's Low: $ 0.50 30 Day Perf: -32.46 %
Volume (M): 277 52 Wk High: $ 1.65
Volume (M$): $ 147 52 Wk Avg: $0.76
Open: $0.54 52 Wk Low: $0.14



 Market Capitalization (Millions $) 37
 Shares Outstanding (Millions) 70
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -32
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) 0

Biosig Technologies Inc
Biosig Technologies Inc is a medical technology company that designs, develops, and commercializes advanced biomedical signal processing systems. Their main product, the PURE EP System, is used for recording, analyzing, and displaying electrophysiological signals for diagnostic and therapeutic procedures in the field of cardiology. This system aims to improve the accuracy, efficiency, and effectiveness of procedures such as ablation, which involves the removal or destruction of abnormal heart tissue. Biosig Technologies focuses on providing innovative solutions that enhance the capabilities of healthcare professionals and ultimately improve patient outcomes in the cardiac electrophysiology field.


   Company Address: 55 Greens Farms Road, 1st Floor Westport 6880 CT
   Company Phone Number: 409-5444   Stock Exchange / Ticker: NASDAQ BSGM
   BSGM is expected to report next financial results on March 30, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Announcement

BioSig Technologies Takes Bold Action to Optimize Operations and Drive Innovation in Medical Technology

Published Tue, Feb 20 2024 3:00 PM UTC

BioSig Technologies, Inc. (NASDAQ: BSGM), a leading medical technology company, has recently made an announcement regarding the reduction of its workforce, which will consequently lead to a substantial decrease in its business operations. This decision comes as part of the company's ongoing efforts to streamline its operations and improve its financial position.According to ...

Biosig Technologies Inc

Disappointing Second Quarter Earnings Paint a Grim Picture for Biosig Technologies IncorBiosig Technologies Inc's Second Quarter 2023 Report Reveals No Growth and Declining Revenue

The latest financial report from Biosig Technologies Inc (BSGM) for the second quarter of 2023 paints a bleak picture for the company. The earnings per share for this quarter reached a dismal $0.00, showing no improvement from the previous year's figures and remaining stagnant compared to the previous reporting season. This lack of growth is concerning and raises doubts about the company's ability to generate profits.
Furthermore, the revenue for this quarter remained unchanged at an abysmal $0.00 million, a significant decline from the $0.01 million reported during the same period last year. This worrisome trend indicates a lack of demand for Biosig Technologies Inc's products, which is a cause for concern for potential investors.






 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com